Leidos, Amazon.com, Halozyme Therapeutics and BioMarin Pharmaceutical are part of the Zacks Screen of the Week article.

Shares of Leidos Holdings Inc. LDOS inched 0.74% higher to $148.24 Monday, on what proved to be an all-around mixed trading ...

The company can trace its incumbency on this program to 2013 and now manufactures some of the airport security equipment ...

Jefferies analyst Sheila Kahyaoglu lowered the firm’s price target on Leidos (LDOS) to $160 from $175 and keeps a Hold rating on the shares.

Leidos (NYSE:LDOS) today announced that its wholly owned subsidiary, QTC Medical Services, operating under the brand name ...

Leidos (LDOS) has been beaten down lately with too much selling pressure. While the stock has lost 12.7% over the past four ...

Learn about how Leidos will provide General Electronic Test Station, or GETS, equipment, hardware, software, upgrades and ...

Leidos Holdings Inc. closed $59.60 below its 52-week high ($202.90), which the company achieved on November 12th.

Rocket Lab USA, Inc. (NASDAQ: RKLB) shares are trading higher Monday following the announcement that the company will play a ...

Four incumbents keep their spots on the vehicle that exceeded its $6.8 billion ceiling as PACT Act claims drives a surge in ...

Learn more about VA's selection of four vendors for a recompete IDIQ contract to provide medical disability examination services in Regions 1 through 4.